EUVIMEDEUVIMED entdecken
Crossref

Hypertriglyceridemia as a Cause of Continuous Renal Replacement Therapy Circuit Clotting: A Case Series

Blaise William Abramovitz, Elizabeth Oguntuwase, Abdelrhman Abo-Zed, Ranil DeSilva

Blood Purification · 2023

DOI: 10.1159/000528574 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Purification, 2023. Verfasst von Blaise William Abramovitz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Renal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Continuous Renal Replacement Therapy, Propofol, Hypertriglyceridemia, Acute Kidney Injury. Die Arbeit wurde bisher 8-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hypertriglyceridemia is a rarely reported cause of early continuous renal replacement therapy (CRRT) circuit clotting.

Methods

We have identified and will present 11 published cases in the literature where hypertriglyceridemia has led to CRRT circuit clotting or dysfunction.

Results

The majority of cases (8/11) are related to propofol use leading to hypertriglyceridemia. The other cases (3/11) are due to total parenteral nutrition administration.

Conclusion

Due to the propensity of propofol use for critically ill patients in intensive care units, and the rather common occurrence of CRRT circuit clotting, hypertriglyceridemia may be underappreciated and undiagnosed. The exact pathophysiology behind hypertriglyceridemia-induced CRRT clotting has not been fully elucidated, although there are some hypotheses which include fibrin and fat droplet deposition (identified after electron microscopic examination of the hemofilter), increased blood viscosity, and development of a procoagulant state. Premature clotting poses a multitude of problems including inadequate treatment time, increased costs, increasing nursing workload, and patient blood loss. With earlier identification, discontinuation of the inciting agent, and possible therapeutic management, we could expect improvement in CRRT hemofilter patency and decreased costs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Continuous Renal Replacement TherapyPropofolHypertriglyceridemiaAcute Kidney InjuryHumansRenal Replacement TherapyBlood CoagulationCritical IllnessAnticoagulants

Stichwörter der Autor:innen

Continuous renal replacement therapyHypertriglyceridemiaPropofol

Substanzen

PropofolAnticoagulants

Autor:innen und Institutionen

  • Renal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Medicine, Mercy Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Zitieren

APA

Abramovitz, B. W., Oguntuwase, E., Abo-Zed, A., & DeSilva, R. (2023). Hypertriglyceridemia as a Cause of Continuous Renal Replacement Therapy Circuit Clotting: A Case Series. Blood Purification. https://doi.org/10.1159/000528574

Vancouver

Abramovitz BW, Oguntuwase E, Abo-Zed A, DeSilva R. Hypertriglyceridemia as a Cause of Continuous Renal Replacement Therapy Circuit Clotting: A Case Series. Blood Purification. 2023. doi:10.1159/000528574

BibTeX
@article{Abramovitz2023,
  author = {Abramovitz, Blaise William and Oguntuwase, Elizabeth and Abo-Zed, Abdelrhman and DeSilva, Ranil},
  title = {Hypertriglyceridemia as a Cause of Continuous Renal Replacement Therapy Circuit Clotting: A Case Series},
  journal = {Blood Purification},
  year = {2023},
  doi = {10.1159/000528574}
}
Kostenlos starten →